BR9307736A - Processo para preparação de formulações farmacêuticas com ingrediente ativo liberado sob controle para administração oral, tópica ou parenteral - Google Patents

Processo para preparação de formulações farmacêuticas com ingrediente ativo liberado sob controle para administração oral, tópica ou parenteral

Info

Publication number
BR9307736A
BR9307736A BR9307736-0A BR9307736A BR9307736A BR 9307736 A BR9307736 A BR 9307736A BR 9307736 A BR9307736 A BR 9307736A BR 9307736 A BR9307736 A BR 9307736A
Authority
BR
Brazil
Prior art keywords
pct
active ingredient
topical
oral
under control
Prior art date
Application number
BR9307736-0A
Other languages
English (en)
Inventor
Giuseppe Motta
Original Assignee
Saitec Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT92BO455 external-priority patent/IT1260242B/it
Priority claimed from ITBO930294A external-priority patent/IT1263445B/it
Priority claimed from IT93BO000460A external-priority patent/IT1268454B1/it
Application filed by Saitec Srl filed Critical Saitec Srl
Publication of BR9307736A publication Critical patent/BR9307736A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção para: <B>"PROCESSO PARA PREPARAçãO DE FORMULAçõES FARMACêUTICAS COM INGREDIENTE ATIVO LIBERADO SOB CONTROLE PARA ADMINISTRAçãO ORAL, TóPICA OU PARENTERAL"<D>. Processo aperfeiçoado para preparação de formulações farmacêuticas com liberação sob controle compreende a exposição da mistura compreendendo um ou mais excipientes e um ou mais ingredientes ativos compatíveis um com o outro e com os ditos excipientes a ações mecânicas ou eletromecânicas, por um período de tempo estabelecido e dentro de uma ampla faixa de freq³ências, para fornecer comprimidos, matrizes ou películas mono ou de multicamada. Ditas formulações podem ser opcionalmente moídas para fornecer um granulado ou pó. Dependendo do excipiente empregado, pode ser obtida uma liberação retardada ou rápida, porém sempre controlada ou ingrediente ativo.
BR9307736-0A 1992-12-23 1993-12-23 Processo para preparação de formulações farmacêuticas com ingrediente ativo liberado sob controle para administração oral, tópica ou parenteral BR9307736A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT92BO455 IT1260242B (it) 1992-12-23 1992-12-23 Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
ITBO930294A IT1263445B (it) 1993-06-24 1993-06-24 Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
IT93BO000460A IT1268454B1 (it) 1993-11-12 1993-11-12 Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
PCT/IT1993/000136 WO1994014421A2 (en) 1992-12-23 1993-12-23 Process for preparing controlled release pharmaceutical forms and the forms thus obtained

Publications (1)

Publication Number Publication Date
BR9307736A true BR9307736A (pt) 1999-08-31

Family

ID=27273889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307736-0A BR9307736A (pt) 1992-12-23 1993-12-23 Processo para preparação de formulações farmacêuticas com ingrediente ativo liberado sob controle para administração oral, tópica ou parenteral

Country Status (14)

Country Link
US (1) US5662935A (pt)
EP (1) EP0675710B1 (pt)
JP (1) JP3459421B2 (pt)
KR (1) KR100297541B1 (pt)
AT (1) ATE183641T1 (pt)
AU (1) AU683044B2 (pt)
BR (1) BR9307736A (pt)
CA (1) CA2151396C (pt)
DE (1) DE69326163T2 (pt)
DK (1) DK0675710T3 (pt)
ES (1) ES2138070T3 (pt)
GR (1) GR3031936T3 (pt)
RU (1) RU2128499C1 (pt)
WO (1) WO1994014421A2 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
IT1292588B1 (it) * 1997-05-28 1999-02-08 Saitec Srl Procedimento per preparare forme alimentari ad elevata resa di sapore e le forme alimentari cosi' ottenute.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
US7201891B1 (en) * 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US20030099703A1 (en) * 2000-08-11 2003-05-29 Shigeru Aoki Drug-containing solid dispersion having improved solubility
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
ITBO20020094A1 (it) 2002-02-22 2003-08-22 Tecnea Engineering S R L Procedimento per la realizzazione di composizioni ed apparecchiatura realizzante tale procedimento
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
WO2005049306A1 (en) * 2003-11-18 2005-06-02 Eurand Pharmaceuticals Limited Ultrasound-assisted compaction process with a compaction device made of coupled plastic-metal materials
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005024171A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Verfahren und Vorrichtung zur Ultraschallverpressung einer Tablette oder einer multipartikulären Arzneiform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
WO2008109723A1 (en) * 2007-03-08 2008-09-12 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
RU2351352C2 (ru) * 2007-04-09 2009-04-10 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Твердая нанокомпозиция для доставки биологически активных веществ
US8383152B2 (en) 2008-01-25 2013-02-26 Gruenenthal Gmbh Pharmaceutical dosage form
SI2273983T1 (sl) 2008-05-09 2016-11-30 Gruenenthal Gmbh Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
TW201105316A (en) 2009-07-22 2011-02-16 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
AU2010275755B2 (en) 2009-07-22 2014-04-24 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EA201401139A1 (ru) 2012-04-18 2015-03-31 Грюненталь Гмбх Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105555847B (zh) 2013-09-19 2018-08-10 微仙美国有限公司 聚合物膜
CN110279885B (zh) 2013-09-19 2022-07-26 泰尔茂株式会社 聚合物颗粒
CN105916495B (zh) 2013-11-08 2019-11-12 泰尔茂株式会社 聚合物颗粒
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
AU2017336786B2 (en) 2016-09-28 2020-04-09 Terumo Corporation Polymer particles

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US3078216A (en) * 1961-04-11 1963-02-19 American Cyanamid Co Prolonged release oral pharmaceutical preparations
US3137630A (en) * 1961-06-09 1964-06-16 Eastman Kodak Co Process for preparing a dry, finely divided, gelatin particle product
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
BR6457270D0 (pt) * 1963-03-04 1973-09-20 Merck & Co Inc Processo de preparacao de uma composicao farmaceutica provendo uma liberacao prolongada de uma droga no aparelho gastro intestinal
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
JPS6094403A (ja) * 1983-10-27 1985-05-27 Nippon Sangaria Bebaretsuji Co:Kk 超音波を利用した粉末製剤の製造方法
US4779806A (en) * 1984-07-23 1988-10-25 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
ES2073507T3 (es) * 1989-04-12 1995-08-16 Procter & Gamble Composiciones de productos solidos de consumo que contienen complejos con ciclodextrina en forma de pequeñas particulas.
JP2958103B2 (ja) * 1989-12-12 1999-10-06 エーザイ株式会社 プラズマ照射固形製剤
JPH03287544A (ja) * 1990-04-05 1991-12-18 Biomaterial Universe Kk 生体分解吸収性高分子材料を用いた徐放性薬剤
FR2664851B1 (fr) * 1990-07-20 1992-10-16 Oreal Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
DK0675710T3 (da) 2000-03-27
CA2151396A1 (en) 1994-07-07
DE69326163T2 (de) 2000-05-04
US5662935A (en) 1997-09-02
ES2138070T3 (es) 2000-01-01
EP0675710B1 (en) 1999-08-25
DE69326163D1 (de) 1999-09-30
GR3031936T3 (en) 2000-03-31
ATE183641T1 (de) 1999-09-15
AU683044B2 (en) 1997-10-30
EP0675710A1 (en) 1995-10-11
KR100297541B1 (ko) 2001-11-26
WO1994014421A3 (en) 1994-08-18
CA2151396C (en) 2006-08-22
JPH08504807A (ja) 1996-05-28
AU6043494A (en) 1994-07-19
WO1994014421A2 (en) 1994-07-07
RU2128499C1 (ru) 1999-04-10
JP3459421B2 (ja) 2003-10-20
KR960700043A (ko) 1996-01-19

Similar Documents

Publication Publication Date Title
BR9307736A (pt) Processo para preparação de formulações farmacêuticas com ingrediente ativo liberado sob controle para administração oral, tópica ou parenteral
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
AU6517496A (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
ATE165734T1 (de) Arzneitablette, die befähigt ist, einen oder mehrere wirkstoffe mit unterschiedlichen abgaberaten freizusetzen
AU1211992A (en) Low dose dry pharmaceutical preparations
AR014133A1 (es) Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
HUT59314A (en) Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration
PT672041E (pt) Derivados da piridina farmacologicamente activos e processos para a sua preparacao
HUT50794A (en) Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients
MX9206236A (es) Composiciones farmaceuticas de liberacion controlada y proceso para su preparacion.
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
AP9400645A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release sold dosage forms of medicaments prepared thereby.
BR9508287A (pt) Formulaçao para a aplicaçao por inalaçao
AU651894B2 (en) Matrix tablet permitting the sustained release of indapamide after oral administration
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
AU2923389A (en) A pharmaceutical composition
IT1258143B (it) Compresse a cessione programmata contenenti naproxen
AU8316291A (en) Galenical preparation method for preparing a therapeutical composition particularly based on aspirin
DE69103724D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
HUT51641A (en) Process for producing pseudoprimycin and its components, as well as pharmaceutical compositions comprising such active ingredient
HUT53355A (en) Process for producing diphenylsulfide derivatives and pharmaceutical compositions comprising such compounds as active ingredient

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
CKFC Appeal: appeal against refusal